gip and glp 1 drugs Indications for GLP-1/GIP RA Summary Sheet Beyond! GLP-1 + GIP Injections -

NEFA, Non-esterified fatty acids

The release of proglucagon causes the liver to make glucose (gluconeogenesis converting protein to glucose) as well as to convert fatty acids into ketone bodies

Endocrinology Advisor Conclusion The 2025 GLP-1 guidelines reflect a paradigm shift in the management of type 2 diabetes, emphasizing the multifaceted benefits of these agents

In addition, section S0 (Non-approved substances) includes substances used for doping which are not included in other sections of the Prohibited List that are not approved by any governmental regulatory health authority for human therapeutic use

PMID 41459016